Quality in Motion: Meet Our Mobile Clinicians: Nikki Degreeff Meet Nikki Degreeff, a Clinical Project Manager who began her journey with PCM Trials as a Certified Mobile Research Nurse (CMRN).
Read More →
The Denver Business Journal details our recent acquisition of Emvenio Research, and our second acquisition of 2024.
Read More →
In partnership with GlobalData, PCM Trials recently hosted a live webinar that offered a look into the evolution and future of decentralized clinical trials (DCTs).
Read More →
Denver (February 23, 2024) – Denver-based PCM Trials, the largest independent mobile research nurse visit provider for decentralized clinical trials (DCTs), today announced the acquisition of EmVenio Research based in Durham, North Carolina.
Read More →
PCM Trials expands its global footprint PCM Trials President Greg Austin spoke with the Denver Business Journal last week about the company’s recent acquisition of Netherlands-based Clinical Trial Service (CTS).
Read More →
Denver (January 10, 2024) – PCM Trials, a Denver, USA-based leader in providing mobile research nurses for decentralized clinical trials, today announced the acquisition of Clinical Trial Service (CTS).
Read More →
On November 14, 2023, industry experts from PCM Trials were joined by trusted logistics vendors for a live webinar featuring lively conversation about overcoming challenges to successfully deliver compliant mobile visits around the world.
Read More →
The clinical trial industry is literally exploding, launching more trials within shorter windows, adding new players, incorporating new technologies and meeting unprecedented regulatory challenges.
Read More →
Decentralized trials (DCTs) have grown in acceptance since the COVID pandemic when mobile research nurses were asked to step in and save hundreds of site-based clinical trials that were in jeopardy of being postponed or cancelled because of mandated lockdowns and fear of spreading the virus.
Read More →
Fully Decentralized Trials: Aspirational Goal Or Reality? The COVID pandemic accelerated the adoption of decentralized trials at a rate never before experienced throughout the Biopharma industry. Sponsors and CROs who
Read More →
